Fulcrum Therapeutics, Inc. [FULC] - Fulcrum Therapeutics / Slate Medicines merger

Fulcrum Therapeutics has entered into a definitive merger agreement to acquire Slate Medicines, where each outstanding share of Slate Common Stock will be converted into Fulcrum Common Stock based on a calculated Exchange Ratio, with the transaction structured as a tax-free reorganization.

View source filing ↗